113 related articles for article (PubMed ID: 1341947)
1. Retrovirus-mediated oncogene transfer into neural transplants.
Wiestler OD; Brüstle O; Eibl RH; Radner H; Aguzzi A; Kleihues P
Brain Pathol; 1992 Jan; 2(1):47-59. PubMed ID: 1341947
[TBL] [Abstract][Full Text] [Related]
2. [Induction of primitive neuroectodermal tumors by oncogene complementation].
von Deimling A; Aguzzi A; Kleihues P; Land H; Wiestler OD
Verh Dtsch Ges Pathol; 1990; 74():432-6. PubMed ID: 1708633
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic activity of the K-fgf/hst oncogene in neural transplants.
Brüstle O; Aguzzi A; Talarico D; Basilico C; Kleihues P; Wiestler OD
Oncogene; 1992 Jun; 7(6):1177-83. PubMed ID: 1375717
[TBL] [Abstract][Full Text] [Related]
4. Oncogene complementation in fetal brain transplants.
Wiestler OD; Aguzzi A; Schneemann M; Eibl R; von Deimling A; Kleihues P
Cancer Res; 1992 Jul; 52(13):3760-7. PubMed ID: 1319831
[TBL] [Abstract][Full Text] [Related]
5. Cell type-specific tumor induction in neural transplants by retrovirus-mediated oncogene transfer.
Aguzzi A; Kleihues P; Heckl K; Wiestler OD
Oncogene; 1991 Jan; 6(1):113-8. PubMed ID: 1992439
[TBL] [Abstract][Full Text] [Related]
6. Tumour induction in fetal brain transplants exposed to the viral oncogenes polyoma middle T and v-src.
Wiestler OD; Aguzzi A; Williams RL; Wagner EF; Boulter CA; Kleihues P
IARC Sci Publ; 1989; (96):267-74. PubMed ID: 2807488
[TBL] [Abstract][Full Text] [Related]
7. A new approach to the molecular basis of neoplastic transformation in the brain.
Wiestler OD; Brüstle O; Eibl RH; Radner H; Von Deimling A; Plate K; Aguzzi A; Kleihues P
Neuropathol Appl Neurobiol; 1992 Oct; 18(5):443-53. PubMed ID: 1333571
[TBL] [Abstract][Full Text] [Related]
8. A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen.
Eibl RH; Kleihues P; Jat PS; Wiestler OD
Am J Pathol; 1994 Mar; 144(3):556-64. PubMed ID: 8129041
[TBL] [Abstract][Full Text] [Related]
9. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
[TBL] [Abstract][Full Text] [Related]
10. Isolation of murine fetal thymus cell lines after infection with recombinant retroviruses containing the v-myc and v-Ha-ras oncogenes.
Cattermole JA; Crosier PS; Leung E; Overell RW; Gillis S; Watson JD
J Immunol; 1989 Jun; 142(11):3746-53. PubMed ID: 2523933
[TBL] [Abstract][Full Text] [Related]
11. Complementary tumor induction in neural grafts exposed to N-ethyl-N-nitrosourea and an activated myc gene.
Brüstle O; Petersen I; Radner H; Höll T; Plate KH; Kleihues P; Wiestler OD
Carcinogenesis; 1993 Aug; 14(8):1715-8. PubMed ID: 8353858
[TBL] [Abstract][Full Text] [Related]
12. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
13. Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice.
Dupressoir A; Heidmann T
Oncogene; 1997 Jun; 14(24):2951-8. PubMed ID: 9205102
[TBL] [Abstract][Full Text] [Related]
14. The effect of oncogenes on the growth and differentiation of oligodendrocyte type 2 astrocyte progenitor cells.
Barnett SC; Crouch DH
Cell Growth Differ; 1995 Jan; 6(1):69-80. PubMed ID: 7718486
[TBL] [Abstract][Full Text] [Related]
15. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells.
Cadoret A; Bertrand F; Baron-Delage S; Lévy P; Courtois G; Gespach C; Capeau J; Cherqui G
Oncogene; 1997 Apr; 14(13):1589-600. PubMed ID: 9129150
[TBL] [Abstract][Full Text] [Related]
17. Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose.
Radner H; el-Shabrawi Y; Eibl RH; Brüstle O; Kenner L; Kleihues P; Wiestler OD
Acta Neuropathol; 1993; 86(5):456-65. PubMed ID: 8310796
[TBL] [Abstract][Full Text] [Related]
18. Retroviral infection of primary hepatocytes from normal mice and mice transgenic for SV40 large T antigen.
Weber-Benarous A; Decaux JF; Bennoun M; Allemand I; Briand P; Kahn A
Exp Cell Res; 1993 Mar; 205(1):91-100. PubMed ID: 7681009
[TBL] [Abstract][Full Text] [Related]
19. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
20. Nervous system modification by transplants and gene transfer.
Doering LC
Bioessays; 1994 Nov; 16(11):825-31. PubMed ID: 7840760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
